Bio-Rad Laboratories (BIO) Research & Development (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Research & Development data on file, last reported at $62.9 million in Q1 2026.

• Research & Development for Q1 2026 came in at $62.9 million, down 14.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $265.0 million (down 12.54% YoY), and the FY2025 annual result was $275.6 million, down 6.86% from the prior year.
• Research & Development slipped to $62.9 million in Q1 2026 per BIO's latest filing, from $70.3 million in the prior quarter.
• Over five years, Research & Development peaked at $91.0 million in Q3 2024 and troughed at $43.5 million in Q3 2023.
• A 5-year average of $67.0 million and a median of $66.2 million in 2022 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2024: Research & Development tumbled 34.84% in 2023, then soared 109.03% in 2024.
• A 5-year view of Research & Development shows it stood at $66.2 million in 2022, then retreated by 3.53% to $63.9 million in 2023, then gained by 24.62% to $79.6 million in 2024, then declined by 11.68% to $70.3 million in 2025, then decreased by 10.53% to $62.9 million in 2026.
• Business Quant data shows BIO's Research & Development at $62.9 million in Q1 2026, $70.3 million in Q4 2025, and $71.3 million in Q3 2025.